Search results for " method"

showing 10 items of 10455 documents

Relationships between 24 h blood pressure load and target organ damage in patients with mild-to-moderate essential hypertension.

2001

Objective: To analyse the relationships between 24 h blood pressure load (the percentage of systolic/diastolic blood pressures exceeding 140/90 mmHg while awake and 120/80 mmHg during sleep) and some indices of hypertensive target organ involvement, independently of the mean level of 24 h blood pressure. Methods: One hundred and thirty patients with mild-to-moderate hypertension underwent 24 h ambulatory blood pressure monitoring, ocular fundus examination, microalbuminuria assay and two-dimensional guided M-mode echocardiography. The study population was divided into subsets according to the systolic and diastolic 24 h blood pressure load values predicted from the regression equation relat…

AdultMalemedicine.medical_specialtyAmbulatory blood pressureFundus OculiSystoleDiastoleBlood PressureAssessment and DiagnosisEssential hypertensionKidneyRetinaElectrolytesDiastoleInternal medicineInternal MedicinemedicineAlbuminuriaHumansSingle-Blind MethodObesityProspective StudiesSystoleAdvanced and Specialized Nursingbusiness.industryMyocardiumGeneral MedicineBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseasePulse pressureMean blood pressureBlood pressuremedicine.anatomical_structureEchocardiographyCreatinineHypertensionVascular resistanceCardiologyFemaleVascular ResistanceCardiology and Cardiovascular MedicinebusinessBlood pressure monitoring
researchProduct

The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.

2001

To determine the antihypertensive efficacy, effect duration and safety of the angiotensin II type 1 receptor blocker candesartan cilexetil and the angiotensin converting enzyme inhibitor enalapril once daily in patients with mild to moderate hypertension.A multicenter, randomised, double-blind parallel group study was performed in Finland, France, the Netherlands, Spain and Sweden. Three-hundred-and-ninety-five men and women in the age range 20-80 years with primary hypertension were randomised to an 8-week double-blind treatment period with either candesartan cilexetil 8-16 mg or enalapril 10-20 mg once daily, with forced dose titration after 4 weeks. Non-invasive ambulatory blood pressure…

AdultMalemedicine.medical_specialtyAmbulatory blood pressureTime Factorsmedicine.medical_treatmentDiastoleTetrazolesAngiotensin-Converting Enzyme InhibitorsBlood PressureAngiotensin Receptor AntagonistsDouble-Blind MethodEnalaprilHeart RateInternal medicineInternal MedicinemedicineHumansProdrugsEnalaprilAntihypertensive AgentsAgedAged 80 and overChemotherapybiologybusiness.industryBiphenyl CompoundsAngiotensin-converting enzymeGeneral MedicineMiddle AgedAngiotensin IICandesartanEndocrinologyTherapeutic EquivalencyACE inhibitorHypertensionbiology.proteinCardiologyBenzimidazolesFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugBlood pressure
researchProduct

Effect of Conjugated Linoleic Acid on Testosterone Levels In Vitro and In Vivo After an Acute Bout of Resistance Exercise

2012

The purposes of the present study were to investigate the effect of conjugated linoleic acid (CLA) supplementation on testosterone levels in vitro on a cell line derived from Leydig cells (R2C) and in vivo in the blood of physically active subjects before and after a resistance exercise bout. In vitro R2C cells were treated with different CLA concentrations (0-30 μM) for 24 and 48 hours. After treatment, supernatant media were tested to determine testosterone secretion. The CLA increased the testosterone secretion only after 48 hours. In vivo, 10 resistance-trained male subjects, in a double-blind placebo-controlled and crossover study design were randomized for 3 weeks of either 6 g·d⁻¹ CL…

AdultMalemedicine.medical_specialtyAnabolismConjugated linoleic acidPhysical Therapy Sports Therapy and RehabilitationCell LineLinoleic Acidchemistry.chemical_compoundSex hormone-binding globulinDouble-Blind MethodIn vivoSex Hormone-Binding GlobulinInternal medicinemedicineAnimalsHumansTestosteroneOrthopedics and Sports MedicineExerciseTestosteroneCross-Over StudiesLeydig cellbiologySettore BIO/16 - Anatomia Umanabusiness.industryfood supplement hormones body composition Leydig cellLeydig CellsResistance TrainingGeneral MedicineCrossover studyRatsmedicine.anatomical_structureEndocrinologychemistryDietary Supplementsbiology.proteinbusinessHormoneJournal of Strength and Conditioning Research
researchProduct

Effects of amino acids supplement on physiological adaptations to resistance training.

2009

KRAEMER, W. J., D. L. HATFIELD, J. S. VOLEK, M. S. FRAGALA, J. L. VINGREN, J. M. ANDERSON, B. A. SPIERING, G. A. THOMAS, J. Y. HO, E. E. QUANN, M. IZQUIERDO, K. HAKKINEN, and C. M. MARESH. Effects of Amino Acids Supplement on Physiological Adaptations to Resistance Training. Med. Sci. Sports Exerc., Vol. 41, No. 5, pp. 1111-1121, 2009. Introduction: Previous research has demonstrated that ingestion of essential amino acids and their metabolites induce anabolic effects with the potential to augment gains in lean body mass and strength after resistance exercise training. Purpose: The purpose of the present study was to examine the effects of an essential amino acid-based formula (Muscle Armor…

AdultMalemedicine.medical_specialtyAnabolismPhysical Therapy Sports Therapy and RehabilitationYoung AdultDouble-Blind MethodInternal medicinemedicineIngestionHumansOrthopedics and Sports MedicineMuscle StrengthAmino AcidsTestosteroneHydrocortisonebiologybusiness.industrySkeletal muscleResistance TrainingAdaptation PhysiologicalEndocrinologymedicine.anatomical_structureDietary SupplementsLean body massbiology.proteinCreatine kinasebusinessmedicine.drugBlood drawingMedicine and science in sports and exercise
researchProduct

Association of Anorexia Nervosa With Risk of Cancer: A Systematic Review and Meta-analysis

2019

This systematic review and meta-analysis evaluates the association of anorexia nervosa with the cancer incidence and mortality among study populations with anorexia nervosa compared with the general population or those without anorexia nervosa.

AdultMalemedicine.medical_specialtyAnorexia NervosaPopulationbehavioral disciplines and activitiesYoung Adult03 medical and health sciences0302 clinical medicineBreast cancerNeoplasmsInternal medicineObservational studymental disordersHumansMedicine030212 general & internal medicineSex DistributionYoung adulteducationOriginal InvestigationAgedCancereducation.field_of_studybusiness.industryResearchMortality ratedigestive oral and skin physiologyCancerGeneral MedicineMiddle Agedmedicine.disease3. Good healthOnline OnlyMeta-analysisOncologyAnorexia nervosa (differential diagnoses)030220 oncology & carcinogenesisMeta-analysisSystematic reviewFemaleEpidemiologic Methodsbusinesshormones hormone substitutes and hormone antagonistsCohort study
researchProduct

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

2007

Summary Background Invasive candidosis is increasingly prevalent in seriously ill patients. Our aim was to compare micafungin with liposomal amphotericin B for the treatment of adult patients with candidaemia or invasive candidosis. Methods We did a double-blind, randomised, multinational non-inferiority study to compare micafungin (100 mg/day) with liposomal amphotericin B (3 mg/kg per day) as first-line treatment of candidaemia and invasive candidosis. The primary endpoint was treatment success, defined as both a clinical and a mycological response at the end of treatment. Primary analyses were done on a per-protocol basis. This trial is registered with ClinicalTrials.gov, number NCT00106…

AdultMalemedicine.medical_specialtyAntifungal AgentsAdolescentLipoproteinsAmphotericin B/ therapeutic useMicrobial Sensitivity TestsLipoproteins/ therapeutic usePeptides CyclicEchinocandinsLipopeptideschemistry.chemical_compoundDouble-Blind MethodAmphotericin BInternal medicineAmphotericin BPeptides Cyclic/ therapeutic usemedicineHumansAdverse effectMycosisFungemiaCandidiasis/complications/ drug therapy/microbiologyAPACHEAgedddc:616Aged 80 and overVoriconazolebusiness.industryAntifungal Agents/ therapeutic useCandidiasisMicafunginGeneral MedicineMiddle Agedbacterial infections and mycosesmedicine.diseaseApacheSurgeryTreatment OutcomechemistryMicafunginFemaleCaspofunginbusinessFluconazolemedicine.drugThe Lancet
researchProduct

German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection

1996

Summary One–hundred and ninety–five patients with toenail tinea unguium were recruited to a multicentre double–blind clinical trial. Patients were given 250mg terbinafine or 200 mg itraconazole daily for 12 weeks, with follow–up for a further 40 weeks. At the end of the study, mycological cure rates were 81% (70/86 assessed) for terbinafine and 63% (53/84 assessed) for itraconazole (two–tailed, P < 0·05). The length of unaffected nail was 9·44 mm in the terbinafine group and 7·85 mm in the itraconazole group (two–tailed, P < 0·05). Patient self–assessment also favoured terbinafine, with 65% evaluating it as good to very good, compared with 58% for itraconazole. Before treatment the terbinaf…

AdultMalemedicine.medical_specialtyAntifungal AgentsItraconazoleDermatologyNaphthalenesDouble blindDouble-Blind MethodOnychomycosismedicineHumansTerbinafineAgedbusiness.industryTinea PedisTinea unguiumMiddle AgedDermatologyClinical trialmedicine.anatomical_structurePatient SatisfactionNail (anatomy)TerbinafineFemaleItraconazoleTinea InfectionbusinessFollow-Up Studiesmedicine.drugBritish Journal of Dermatology
researchProduct

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targ…

2006

BACKGROUND: Despite the prognostic value of metabolic syndrome for predicting cardiovascular events, few trials have investigated the effects of statin therapy on cardiovascular morbidity and mortality in patients with the metabolic syndrome. Our post hoc analysis of the Treating to New Targets (TNT) study assessed whether intensive lowering of low-density lipoprotein cholesterol with high-dose atorvastatin therapy results in cardiovascular benefits for patients with both coronary heart disease and the metabolic syndrome. METHODS: The TNT study was a prospective, double blind, parallel-group trial done at 256 sites in 14 countries between April, 1998, and August, 2004, with a median follow-…

AdultMalemedicine.medical_specialtyAtorvastatinCoronary Diseaselaw.inventionDiabetes Complicationschemistry.chemical_compoundDouble-Blind MethodRandomized controlled trialRisk FactorslawInternal medicineDiabetes mellitusAtorvastatinmedicineHumansPyrrolesMyocardial infarctionStrokeAgedMetabolic SyndromeDose-Response Relationship Drugbusiness.industryCholesterolAnticholesteremic AgentsHazard ratioCholesterol LDLGeneral MedicineMiddle Agedmedicine.diseaseSurgerychemistryCardiovascular DiseasesHeptanoic AcidsCardiologyFemaleMetabolic syndromebusinessmedicine.drug
researchProduct

Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms.

2014

Recently, Functional Remediation (FR) has proven to be effective in improving the functional outcome of euthymic bipolar patients. The aim of this study was to test the efficacy of the FR program in a subsample of euthymic bipolar II patients (BPII). A post-hoc analyses were undertaken using data of 53 BPII outpatients who had participated in a multicenter, rater-blind, randomized, controlled trial exploring the efficacy of FR (n=17) as compared with a Psychoeducation group (PSY) (n=19) and a treatment as usual control group (TAU n=17). The primary outcome variable was the functional improvement defined as the mean change in the Functioning Assessment Short Test (FAST) from baseline to endp…

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentlaw.inventionBipolar II disorderCognitionRandomized controlled triallawInternal medicinePsychoeducationmedicineHumansPharmacology (medical)Single-Blind MethodBipolar disorderBiological PsychiatryPharmacologyPsychiatric Status Rating ScalesCognitive Behavioral Therapymedicine.diseaseCognitive behavioral therapyPsychiatry and Mental healthTreatment OutcomeNeurologyCognitive remediation therapyFemaleNeurology (clinical)medicine.symptomPsychologyNeurocognitiveManiaClinical psychologyEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.

2013

The main objective was to compare the mean change in augmentation index of hypertensive patients treated with nebivolol or atenolol.Multicenter, double-blind randomized study conducted in six Spanish centers. We enrolled outpatients between the ages of 40 and 65 years with mild or moderate essential hypertension (systolic blood pressure, SBP ≥ 140 mmHg to ≤ 179 mmHg and diastolic blood pressure, DBP ≥ 90 mmHg to ≤ 109 mmHg after a 2-week run-in placebo period). Patients received nebivolol 5 mg or atenolol 50 mg once daily. At week 3, atenolol could be titrated up to 100 mg qd for non-responders. Additionally, patients not achieving normal blood pressure after 6 weeks could be treated with 2…

AdultMalemedicine.medical_specialtyBlood PressureEssential hypertensionlaw.inventionNebivololHydrochlorothiazideRandomized controlled trialDouble-Blind MethodlawInternal medicineInternal MedicinemedicineHumansBenzopyransAntihypertensive AgentsAgedbusiness.industryGeneral MedicineMiddle AgedAtenololmedicine.diseaseNebivololPulse pressureBlood pressureAtenololEthanolaminesAnesthesiaHypertensionCardiologyAortic pressureFemaleEssential HypertensionCardiology and Cardiovascular Medicinebusinessmedicine.drugBlood pressure
researchProduct